![]() |
Volumn 104, Issue 1, 2013, Pages 67-91
|
Donor selection and release criteria of cellular therapy products
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALYTIC METHOD;
ARTICLE;
CELL COUNT;
CELL ENGINEERING;
CELL EXPANSION;
CELL THERAPY;
CELL VIABILITY;
CLINICAL PROTOCOL;
CRYOPRESERVATION;
DONOR SELECTION;
HUMAN;
IMMUNOPHENOTYPING;
LIVING DONOR;
MESENCHYMAL STEM CELL;
NONHUMAN;
PRIORITY JOURNAL;
QUALITY CONTROL;
TISSUE ENGINEERING;
BLOOD BANKS;
BLOOD DONORS;
BLOOD SAFETY;
BLOOD TRANSFUSION;
DONOR SELECTION;
HUMANS;
INTERNATIONAL COOPERATION;
PATIENT SAFETY;
QUALITY CONTROL;
QUESTIONNAIRES;
TISSUE DONORS;
TISSUE THERAPY;
|
EID: 84871319702
PISSN: 00429007
EISSN: 14230410
Source Type: Journal
DOI: 10.1111/j.1423-0410.2012.01619.x Document Type: Article |
Times cited : (8)
|
References (0)
|